These Analysts Boost Their Forecasts On Liquidia

Why did a federal court block Trump's tariffs? How will tariffs impact Gap's 2025 profits? What caused Nvidia's stock surge despite China restrictions? Why did e.l.f. acquire Hailey Bieber's skincare brand? How is AI reshaping hiring at Salesforce? Why is Victoria's Secret website down currently? What effects will Trump's visa revocations have on universities?

These Analysts Boost Their Forecasts On Liquidia

benzinga.com/25/05/45647727/these-analysts-boost-their-forecasts-on-liquidia

On Friday, the U.S. Food and Drug Administration (FDA) approved Liquidia Corporation's (NASDAQ:LQDA) Yutrepia (treprostinil) inhalation powder, a prostacyclin analog for adults with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease…

This story appeared on benzinga.com, 2025-05-28 15:08:19.